Clearside Biomedical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.

About CLSD

Clearside Biomedical, Inc. is a biopharmaceutical company that delivers therapies to the back of the eye through the suprachoroidal space. Its SCS microinjector enables a simple, repeatable, in-office procedure to deliver treatments directly to the macula, retina, or choroid, potentially helping to preserve and improve vision in patients with serious eye diseases. 

CEO
George M. Lasezkay
CEOGeorge M. Lasezkay
Employees
32
Employees32
Headquarters
Alpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded
2011
Founded2011
Employees
32
Employees32

CLSD Key Statistics

Market cap
58.29M
Market cap58.29M
Price-Earnings ratio
-1.87
Price-Earnings ratio-1.87
Dividend yield
Dividend yield
Average volume
200.66K
Average volume200.66K
High today
$0.778
High today$0.778
Low today
$0.75
Low today$0.75
Open price
$0.778
Open price$0.778
Volume
152.42K
Volume152.42K
52 Week high
$1.65
52 Week high$1.65
52 Week low
$0.7001
52 Week low$0.7001

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CLSD. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.